Main Page

HemOnc.org - A Free Hematology/Oncology Reference

4,428 regimens on HemOnc.org

6,546 variants on HemOnc.org

Created as a knowledge base for hematology & oncology providers, HemOnc.org is a collaborative wiki containing details about 100s of hematology/oncology drugs, and 1000s of antineoplastic regimens. Content is added by hematology & oncology providers, and undergoes continuous peer review.

If this is your first time visiting, please go to the tutorial page or just start exploring!
Desktop Version of HemOnc.org | Mobile (phone/tablet) Version of HemOnc.org
How to add a HemOnc.org shortcut to your mobile device's home screen
Hematology Oncology Fellowship Programs Directory

Quick links to chemotherapy regimens
Solid tumors
Anal cancer	Bladder cancer	Bone cancer	Breast cancer
Breast cancer, HER-2 positive	Central nervous system (CNS) cancer	Cervical cancer	Colon cancer
Esophageal cancer	Ewing's sarcoma	Gastric cancer	Gastrointestinal stromal tumor (GIST)
Germ cell tumors	Head and neck cancer	Hepatobiliary cancer	Lung cancer, non-small cell (NSCLC)
Lung cancer, small cell (SCLC)	Melanoma	Merkel cell carcinoma	Mesothelioma
Neuroblastoma	Neuroendocrine tumors	Osteosarcoma	Ovarian cancer
Pancreatic cancer	Penile cancer	Prostate cancer	Rectal cancer
Renal cancer (RCC)	Sarcoma	Skin, basal & squamous cancer	Testicular cancer
Thymoma	Thyroid cancer	Unknown primary	Uterine cancer
Acute leukemias
Acute myeloid leukemia (AML)	Acute promyelocytic leukemia (APL)	B-cell acute lymphoblastic leukemia (B-ALL)	T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/T-LBL)
CNS leukemia	Transplant conditioning regimens
Myeloproliferative neoplasms and myelodysplastic syndromes
Chronic myelogenous leukemia (CML)	Chronic myelomonocytic leukemia (CMML)	Essential thrombocythemia (ET)	Hypereosinophilic syndrome (HES)
Myelodysplastic syndrome	Primary & secondary myelofibrosis	Polycythemia vera (PV)	Systemic mastocytosis
Mature B-, T-, and NK-cell neoplasms
Adult T-cell leukemia-lymphoma (ATLL)	Anaplastic large cell lymphoma (ALCL)	Burkitt lymphoma (BL) or Burkitt-like lymphoma	Chronic lymphocytic leukemia (CLL/SLL)
CNS lymphoma	Cutaneous T-cell lymphoma (CTCL)	Diffuse large B-cell lymphoma (DLBCL)	Extranodal NK/T-cell lymphoma, nasal type
Follicular lymphoma (FL)	Hairy cell leukemia (HCL)	HIV-associated lymphoma	Hodgkin lymphoma (HL)
Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)	Large granular lymphocytic (LGL) leukemia	Light-chain (AL) amyloidosis	Mantle cell lymphoma (MCL)
Marginal zone lymphoma (MZL)	Mediastinal gray-zone lymphoma (MGZL)	Multiple myeloma (MM)	NK/T-cell lymphoma
Peripheral T-cell Lymphoma (PTCL)	Plasma cell leukemia	Post-transplant lymphoproliferative disorder (PTLD)	Primary mediastinal B-cell lymphoma (PMBL)
Transformed lymphoma (TL)	Transplant conditioning regimens	Waldenström macroglobulinemia (WM/LPL)
Other hematology
Aplastic anemia	Atypical hemolytic-uremic syndrome (aHUS)	Autoimmune cytopenias	Autoimmune thrombocytopenic purpura (ITP)
Castleman disease	Coagulopathies	Cold agglutinin disease	Hemophagocytic lymphohistiocytosis (HLH)
Histiocytoses	Paroxysmal nocturnal hemoglobinuria (PNH)	Sickle cell anemia	Thrombotic thrombocytopenic purpura (TTP)
Venous thromboembolism (VTE)

Browse our complete index of pages

Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. Priorities of this project include:

1. Creating a database of chemotherapy agents and other medications.
2. Creating a database of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
3. Sample order sets and examples of supportive medications used with treatment regimens
4. Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.

Additional possibilities for this project may include:

1. Creating summaries of pivotal clinical trials
2. Establishing homepages for ongoing clinical trials that contain information and sites of participation
3. Checklists for common clinical scenarios/diseases
4. Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects

The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.